The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Dominant Negative ATM Mutations in Breast Cancer Families
Open accessAbstract
BACKGROUND: The ATM gene encoding a putative protein kinase is mutated in ataxia-telangiectasia (A-T), an autosomal recessive disorder with a predisposition for cancer. Studies of A-T families suggest that female heterozygotes have an increased risk of breast cancer compared with noncarriers. However, neither linkage analyses nor mutation studies have provided supporting evidence for a role of ATM in breast cancer predisposition. Nevertheless, two recurrent ATM mutations, T7271G and IVS10-6T-->G, reportedly increase the risk of breast cancer. We examined these two ATM mutations in a population-based, case-control series of breast cancer families and multiple-case breast cancer families. METHODS: Five hundred twenty-five or 262 case patients with breast cancer and 381 or 68 control subjects, respectively, were genotyped for the T7271G and IVS10-6T-->G ATM mutations, as were index patients from 76 non-BRCA1/2 multiple-case breast cancer families. Linkage and penetrance were analyzed. ATM protein expression and kinase activity were analyzed in lymphoblastoid cell lines from mutation carriers. All statistical tests were two-sided. RESULTS: In case and control subjects unselected for family history of breast cancer, one case patient had the T7271G mutation, and none had the IVS10-6T-->G mutation. In three multiple-case families, one of these two mutations segregated with breast cancer. The estimated average penetrance of the mutations was 60% (95% confidence interval [CI] = 32% to 90%) to age 70 years, equivalent to a 15.7-fold (95% CI = 6.4-fold to 38.0-fold) increased relative risk compared with that of the general population. Expression and activity analyses of ATM in heterozygous cell lines indicated that both mutations are dominant negative. CONCLUSION: At least two ATM mutations are associated with a sufficiently high risk of breast cancer to be found in multiple-case breast cancer families. Full mutation analysis of the ATM gene in such families could help clarify the role of ATM in breast cancer susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
DNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
Self-citationActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Easton, D. F., Bishop, D. T., Ford, D., & Crockford, G. P. (1993) · Europe PMC (PubMed Central) · Cited by 1,243
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
Incidence of Cancer in 161 Families Affected by Ataxia–Telangiectasia
Swift, M., Morrell, D., Massey, R. B., & Chase, C. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252602 · Cited by 939
Breast and Other Cancers in Families with Ataxia-Telangiectasia
Swift, M., Reitnauer, P. J., Morrell, D., & Chase, C. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705213162101 · Cited by 719
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
Tibbetts, R. S., Cortez, D., Brumbaugh, K. M., Scully, R., Livingston, D., Elledge, S. J., & Abraham, R. T. (2000) · Genes & Development · doi:10.1101/gad.851000 · Cited by 512
ATM associates with and phosphorylates p53: mapping the region of interaction
Khanna., K. K., Keating, K. E., Kozlov, S., Scott, S., Gatei, M., Hobson, K., Taya, Y., Gabrielli, B., Chan, D., Lees-Miller, S. P., et al. (1998) · Nature Genetics · doi:10.1038/3882 · Cited by 486
Stankovic, T., Kidd, A. M. J., Sutcliffe, A., McGuire, G. M., Robinson, P., Weber, P., Bedenham, T., Bradwell, A. R., Easton, D. F., Lennox, G. G., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301706 · Cited by 400
Heterozygous ATM mutations do not contribute to early onset of breast cancer
FitzGerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, D. P., Finkelstein, D. M., Isselbacher, K. J., & Haber, D. A. (1997) · Nature Genetics · doi:10.1038/ng0397-307 · Cited by 340
Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer
Athma, P., Rappaport, R., & Swift, M. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00328-7 · Cited by 330
Levi, S., Urbano-Ispizúa, Á., Gill, R., Thomas, D. M., Gilbertson, J. A., Foster, C., & Marshall, C. J. (1991) · PubMed · Cited by 328
Splicing Defects in the Ataxia-Telangiectasia Gene, ATM: Underlying Mutations and Consequences
Teraoka, S. N., Telatar, M., Becker-Catania, S., Liang, T., Önengüt, S., Tolun, A., Chessa, L., Sanal, Ö., Bernatowska, E., Gatti, R. A., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302418 · Cited by 316
Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families
Easton, D., Bishop, D., Ford, D., Crockford, G., Haites, N., Milner, B. J., Allan, L., King, M., Bowcock, A. M., Anderson, L., et al. (1993) · UCL Discovery (University College London) · Cited by 309
Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei, M. H., Scott, S. P., Filippovitch, I., Soronika, N., Lavin, M. F., Weber, B. L., & Khanna, K. K. (2000) · PubMed · Cited by 295
Cancer risks in A-T heterozygotes
Easton, D. F. (1994) · International Journal of Radiation Biology · doi:10.1080/09553002.1994.11772027 · Cited by 289
Gatti, R. A., Tward, A., & Concannon, P. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2942 · Cited by 280
Hopper, J. L., Southey, M. C., Dite, G. S., Jolley, D. J., Giles, G. G., McCredie, M. R. E., Easton, D. F., & Venter, D. J. (1999) · PubMed · Cited by 260
ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility
Broeks, A., Urbanus, J. H. M., Floore, A. N., Dahler, E. C., Klijn, J. G. M., Rutgers, E. J. T., Devilee, P., Russell, N. S., van Leeuwen, F. E., & van't Veer, L. J. (2000) · The American Journal of Human Genetics · doi:10.1086/302746 · Cited by 240
Cancer in Patients With Ataxia-Telangiectasia and in Their Relatives in the Nordic Countries
Olsen, J. H., Hahnemann, J. M., Borresen-Dale, A.-L., Brondum-Nielsen, K., Hammarstrom, L., Kleinerman, R., Kaariainen, H., Lonnqvist, T., Sankila, R., Seersholm, N., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.2.121 · Cited by 237
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood
Vu, B. L., de Vathaire, F., Shamsaldin, A., Hawkins, M. M., Grimaud, E., Hardiman, C., Diallo, I., Vassal, G., Bessa, E., Campbell, S., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3<354::aid-ijc8>3.0.co;2-n · Cited by 193
Fragments of ATM Which Have Dominant-Negative or Complementing Activity
Morgan, S. E., Lovly, C., Pandita, T. K., Shiloh, Y., & Kastan, M. B. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2020 · Cited by 162
Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
Dörk, T., Bendix, R., Bremer, M., Rades, D., Klöpper, K., Nicke, M., Skawran, B., Hector, A., Yamini, P., Steinmann, D., et al. (2001) · PubMed · Cited by 151
Vořechovský, I., Rasio, D., Luo, L., Monaco, C., Hammarström, L. L. G., WEBSTER, A. D. B., Žaloudík, J., Barbanti-Brodani, G., James, M. R., & Russo, G. (1996) · PubMed · Cited by 147
Cancer risk in heterozygotes for ataxia-telangiectasia
Geoffroy-Perez, B., Janin, N., Ossian, K., Laug�, A., Croquette, M.-F., Griscelli, C., Debr�, M., Paillerets, B. B., Aurias, A., Stoppa‐Lyonnet, D., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1329 · Cited by 134
ATM mutations in cancer families.
Vořechovský, I., Luo, L., Lindblom, A., Negrini, M., WEBSTER, A. D. B., Croce, C. M., & Hammarström, L. L. G. (1996) · PubMed · Cited by 134
Faster Linkage Analysis Computations for Pedigrees with Loops or Unused Alleles
Schäffer, A. A. (1996) · Human Heredity · doi:10.1159/000154358 · Cited by 128
The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
Chen, J., Birkholtz, G. G., Lindblom, P., Rubio‐Terres, C., & Lindblom, A. (1998) · PubMed · Cited by 118
Janin, N., Andrieu, N., Ossian, K., Laugé, A., Croquette, M.-F., Griscelli, C., Debré, M., Paillerets, B. B., Aurias, A., & Stoppa‐Lyonnet, D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690460 · Cited by 109
Izatt, L., Greenman, J., Hodgson, S. V., Ellis, D., Watts, S., Scott, G., Jacobs, C., Liebmann, R. D., Zvelebil, M., Mathew, C. G., et al. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199912)26:4<286::aid-gcc2>3.0.co;2-x · Cited by 107
Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia
Inskip, H. M., Kinlen, L. J., Taylor, A. M. R., Woods, C. G., & Arlett, C. F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690209 · Cited by 103
Shayeghi, M., Seal, S., Regan, J., Collins, N., Barfoot, R., Rahman, N., Ashton, A., Moohan, M., Wooster, R., Owen, R., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.602 · Cited by 69
Background, rationale and protocol for a case-control-family study of breast cancer
Hopper, J. L., Giles, G. G., McCredie, M. R. E., & Boyle, P. (1994) · The Breast · doi:10.1016/0960-9776(94)90003-5 · Cited by 65
Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients
Ramsay, J., Birrell, G. W., & Lavin, M. F. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00014-0 · Cited by 65
Absence of linkage to the ataxia telangiectasia locus in familial breast cancer
Wooster, R., Ford, D., Mangion, J., Ponder, B. A. J., Peto, J., Easton, D. F., & R-Stratton, M. (1993) · Human Genetics · doi:10.1007/bf00216153 · Cited by 58
Missense Mutations in Disease Genes: A Bayesian Approach to Evaluate Causality
Petersen, G. M., Parmigiani, G., & Thomas, D. C. (1998) · The American Journal of Human Genetics · doi:10.1086/301871 · Cited by 47
kConFab: a research resource of Australasian breast cancer families
Osborne, R. H., Hopper, J. L., Kirk, J. A., Chenevix‐Trench, G., Thorne, H. J., & Sambrook, J. (2000) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb124064.x · Cited by 45
Self-citationBroeks, N. S. R. A. (2000) · International Journal of Radiation Biology · doi:10.1080/095530000138367 · Cited by 42
Chenevix‐Trench, G., Kerr, J., Friedlander, M., Hurst, T., Sanderson, B. J. S., Coglan, M., Ward, B. G., Leary, J., & Khoo, S. K. (1994) · PubMed · Cited by 26
Self-citation
Cited by
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
Mateo, J., Carreira, S., Sandhu, S., Miranda, S., Mossop, H., Perez-Lopez, R., Nava Rodrigues, D., Robinson, D., Omlin, A., Tunariu, N., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506859 · Cited by 2,185
BRCA1 and BRCA2: 1994 and beyond
Narod, S. A., & Foulkes, W. D. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1431 · Cited by 967
Chromosome Abnormalities and Genetic Counseling
Gardner, R. J. M., Sutherland, G. R., & Shaffer, L. G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780195375336.001.0001 · Cited by 857
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
The Breast Cancer Susceptibility Collaboration (UK), Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., North, B., Jayatilake, H., Barfoot, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1837 · Cited by 743
Wooster, R., & Weber, B. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012284 · Cited by 605
Metadata
- Authors
- Chenevix-Trench, G.
- Venue
- CancerSpectrum Knowledge Environment
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-02-06
- Volume
- 94
- Issue
- 3
- Pages
- 205-215
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2138650839
- Cited by
- 376
- References
- 42
- FWCI
- 30.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.